Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Adverum Biotechnologies Inc. buy krebskrebs

Start price
€1.97
26.07.21 / 50%
Target price
€3.00
26.07.22
Performance (%)
-23.63%
End price
€1.50
27.07.22
Summary
This prediction ended on 27.07.22 with a price of €1.50. The prediction for Adverum Biotechnologies Inc. disappointed with a performance of -23.63%. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Adverum Biotechnologies Inc. - - -
iShares Core DAX® 0.000% -2.064% 13.111%
iShares Nasdaq 100 0.626% -2.884% 37.744%
iShares Nikkei 225® 1.568% -5.892% 19.592%
iShares S&P 500 0.334% -2.281% 27.745%

Comments by krebskrebs for this prediction

In the thread Adverum Biotechnologies Inc. diskutieren
Prediction Buy
Perf. (%) -23.63%
Target price 3.000
Change
Ends at

Buy mit Kursziel 3,0

In the thread Trading Adverum Biotechnologies Inc.
Prediction Buy
Perf. (%) -23.63%
Target price 3.000
Change
Ends at 26.07.22

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten